Name: Systems Pharmacology and Pharmacodynamics (en Inglés)
Price: 1065097.00 COP
Availability: InStock
Author: Mager, Donald E. ; Kimko, Holly H. C.
ISBN: 9783319830742

portada Systems Pharmacology and Pharmacodynamics (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Mager, Donald E. ; Kimko, Holly H. C.

Idioma

Inglés

N° páginas

511

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 2.7 cm

Peso

0.73 kg.

ISBN13

9783319830742

Categorías

Farmacología
Farmacia y prescripción
Matemáticas aplicadas

Systems Pharmacology and Pharmacodynamics (en Inglés)

Mager, Donald E. ; Kimko, Holly H. C. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 1.065.097

$ 2.130.194

Ahorras: $ 1.065.097

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 06 de Agosto y el Martes 20 de Agosto.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Systems Pharmacology and Pharmacodynamics (en Inglés)"

While systems biology and pharmacodynamics have evolved in parallel, there are significant interrelationships that can enhance drug discovery and enable optimized therapy for each patient. Systems pharmacology is the relatively new discipline that is the interface between these two methods. This book is the first to cover the expertise from systems biology and pharmacodynamics researchers, describing how systems pharmacology may be developed and refined further to show practical applications in drug development. There is a growing awareness that pharmaceutical companies should reduce the high attrition in the pipeline due to insufficient efficacy or toxicity found in proof-of-concept and/or Phase II studies. Systems Pharmacology and Pharmacodynamics discusses the framework for integrating information obtained from understanding physiological/pathological pathways (normal body function system vs. perturbed system due to disease) and pharmacological targets in order to predict clinical efficacy and adverse events through iterations between mathematical modeling and experimentation.